RGT 2.99% 32.5¢ argent biopharma limited

there are a bunch of gmp approved european hops facilities...

  1. 43 Posts.
    lightbulb Created with Sketch. 11
    there are a bunch of gmp approved european hops facilities turning to cannabis processing quickly! but that will be more for the mass market retailer commerce. and most of them are probably not extract ready so whoever is buying from them is buying a really raw product and then they need to process into finished consumer good. mgc really needs to attenuate their specialized facilities to pump out extracts and isolates and neutraceuticals and medical formulations and the attention to detail their products out of their euro facilities can have. Execution will need to be precise with few hiccups. Its pretty common knowledge that were hiccups(packaging and containers) on the mgc derma rollout to cult beauty and varm test batch. But!! The hiccup is hopefully out of the way for the retail store UK rollout. If they would have had that hiccup on retail that could have been really bad. major brand interactions happen in brick and mortar. execution and attention to detail will be key as they scale up on cannepil and other products. the market is just going to laugh and dump from here on out at failed execution attempts.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
32.5¢
Change
-0.010(2.99%)
Mkt cap ! $15.73M
Open High Low Value Volume
32.0¢ 32.5¢ 32.0¢ $2.203K 6.783K

Buyers (Bids)

No. Vol. Price($)
1 1666 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 8746 1
View Market Depth
Last trade - 14.31pm 17/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.